Aerobic fitness and body mass index in individuals with schizophrenia: Implications for neurocognition and daily functioning

Psychiatry Research

Volumn 220, Issue 3, 2014, Pages 784-791

  Kimhy, David ^a,b   Vakhrusheva, Julia ^a   Bartels, Matthew N ^c   Armstrong, Hilary F ^d,e   Ballon, Jacob S ^a,b   Khan, Samira ^b   Chang, Rachel W ^b   Hansen, Marie C ^b   Ayanruoh, Lindsey ^b   Smith, Edward E ^a,b   Sloan, Richard P ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e Department of Medicine   (United States)

Author keywords

Aerobic fitness; Body mass index; Daily functioning; Neurocognition; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; AEROBIC EXERCISE; ARTICLE; BODY MASS; COGNITION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; EXERCISE INTENSITY; FEMALE; FITNESS; HUMAN; MALE; RESPONSE TIME; SCHIZOPHRENIA; SELF CARE; WORKING MEMORY; ADOLESCENT; COGNITIVE DEFECT; COMPLICATION; CROSS-SECTIONAL STUDY; EXERCISE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGY; YOUNG ADULT;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; BODY MASS INDEX; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; EXERCISE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84919632473     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.08.052     Document Type: Article

References (70)

1. Abdul Rashid N., Lim J., Chong S., Keefe R., Lee J. Unraveling the relationship between obesity, schizoprhenia, and cognition. Schizophrenia Research 2013, 151:107-112.
2. Adlard P.A., Perreau V.M., Pop V., Cotman C.W. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. Journal of Neuroscience 2005, 25:4217-4221.
3. Barch D.M., Keefe R.S. Anticipating DSM-V: opportunities and challenges for cognition and psychosis. Schizophrenia Bulletin 2010, 36:43-47.
4. Binder D.K., Scharfman H.E. Brain-derived neurotrophic factor. Growth Factors 2004, 22:123-131.
5. Borg G. Borg's Perceived Exertion and Pain Scales 1998, Human Kinetics, Champaign, IL.
6. Boyer L., Richieri R., Dassa D., Boucekine M., Fernandez J., Vaillant F., Padovani R., Auquier P., Lancon C. Association of metabolic syndrome and inflammation with neurocognition in patients with schizophrenia. Psychiatry Research 2013, 210:381-386.
7. Buchanan R.W., Keefe R.S., Lieberman J.A., Barch D.M., Csernansky J.G., Goff D.C., Gold J.M., Green M.F., Jarskog L.F., Javitt D.C., Kimhy D., Kraus M.S., McEvoy J.P., Mesholam-Gately R.I., Seidman L.J., Ball M.P., McMahon R.P., Kern R.S., Robinson J., Marder S.R. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biological Psychiatry 2011, 69:442-449.
8. Casey B.J., Glatt C.E., Tottenham N., Soliman F., Bath K., Amso D., Altemus M., Pattwell S., Jones R., Levita L., McEwen B., Magarinos A.M., Gunnar M., Thomas K.M., Mezey J., Clark A.G., Hempstead B.L., Lee F.S. Brain-derived neurotrophic factor as a model system for examining gene by environment interactions across development. Neuroscience 2009, 164:108-120.
9. Castren E., Berninger B., Leingartner A., Lindholm D. Regulation of brain-derived neurotrophic factor mRNA levels in hippocampus by neuronal activity. Progress in Brain Research 1998, 117:57-64.
10. Colcombe S., Kramer A.F. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychological Science 2003, 14:125-130.
11. Craig C.L., Marshall A.L., Sjostrom M., Bauman A.E., Booth M.L., Ainsworth B.E., Pratt M., Ekelund U., Yngve A., Sallis J.F., Oja P. International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise 2003, 35:1381-1395.
12. Daumit G.L., Goldberg R.W., Anthony C., Dickerson F., Brown C.H., Kreyenbuhl J., Wohlheiter K., Dixon L.B. Physical activity patterns in adults with severe mental illness. Journal of Nervous and Mental Disease 2005, 193:641-646.
13. Dixon L.B., Dickerson F., Bellack A.S., Bennett M., Dickinson D., Goldberg R.W., Lehman A., Tenhula W.N., Calmes C., Pasillas R.M., Peer J., Kreyenbuhl J. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophrenia Bulletin 2010, 36:48-70. Schizophrenia Patient Outcomes Research Team.
14. Faulkner G., Cohn T., Remington G. Validation of a physical activity assessment tool for individuals with schizophrenia. Schizophrenia Research 2006, 82:225-231.
15. Fornitano L.D., Godoy M.F. Exercise testing in individuals with morbid obesity. Obesity Surgery 2010, 20:583-588.
16. Friedman J.I., Wallenstein S., Moshier E., Parrella M., White L., Bowler S., Gottlieb S., Harvey P.D., McGinn T.G., Flanagan L., Davis K.L. The effects of hypertension and body mass index on cognition in schizophrenia. The American Journal of Psychiatry 2010, 167:1232-1239.
17. Gobbo O.L., O'Mara S.M. Exercise, but not environmental enrichment, improves learning after kainic acid-induced hippocampal neurodegeneration in association with an increase in brain-derived neurotrophic factor. Behavioural Brain Research 2005, 159:21-26.
18. Goff D.C., Hill M., Barch D. The treatment of cognitive impairment in schizophrenia. Pharmacology, Biochemistry, and Behavior 2011, 99:245-253.
19. Gold J.M. Cognitive deficits as treatment targets in schizophrenia. Schizophrenia Research 2004, 72:21-28.
20. Gorczynski P., Faulkner G. Exercise therapy for schizophrenia. Cochrane Database of Systematic Reviews 2010, 5:CD004412.
21. Grealy M.A., Johnson D.A., Rushton S.K. Improving cognitive function after brain injury: the use of exercise and virtual reality. Archives of Physical Medicine and Rehabilitation 1999, 80:661-667.
22. Green M.F. Stimulating the development of drug treatments to improve cognition in schizophrenia. Annual Review of Clinical Psychology 2007, 3:159-180.
23. Green M.J., Matheson S.L., Shepherd A., Weickert C.S., Carr V.J. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Molecular Psychiatry 2011, 16:960-972.
24. Guo X., Zhang Z., Wei Q., Lv H., Wu R., Zhao J. The relationship between obesity and neurocognitive function in Chinese patients with schizophrenia. BMC Psychiatry 2013, 13:109.
25. Harvey P.D. Assessment of everyday functioning in schizophrenia. Innovations in Clinical Neuroscience 2011, 8:21-24.
26. Hennigan A., O'Callaghan R.M., Kelly A.M. Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. Biochemical Society Transactions 2007, 35:424-427.
27. Hillman C.H., Erickson K.I., Kramer A.F. Be smart, exercise your heart: exercise effects on brain and cognition. Nature Review Neuroscience 2008, 9:58-65.
28. Javitt D.C., Buchanan R.W., Keefe R.S., Kern R., McMahon R.P., Green M.F., Lieberman J., Goff D.C., Csernansky J.G., McEvoy J.P., Jarskog F., Seidman L.J., Gold J.M., Kimhy D., Nolan K.S., Barch D.S., Ball M.P., Robinson J., Marder S.R. Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophrenia Research 2012, 136:25-31.
29. Jindal R.D., Pillai A.K., Mahadik S.P., Eklund K., Montrose D.M., Keshavan M.S. Decreased BDNF in patients with antipsychotic naive first episode schizophrenia. Schizophrenia Research 2010, 119:47-51.
30. Johnston M.V. Plasticity in the developing brain: implications for rehabilitation. Developmental Disabilities Research Reviews 2009, 15:94-101.
31. Kaspar B.K., Frost L.M., Christian L., Umapathi P., Gage F.H. Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Annals of Neurology 2005, 57:649-655.
32. Keefe R.S., Bilder R.M., Davis S.M., Harvey P.D., Palmer B.W., Gold J.M., Meltzer H.Y., Green M.F., Capuano G., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Davis C.E., Hsiao J.K., Lieberman J.A. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Archives of General Psychiatry 2007, 64:633-647.
33. Kimhy D., Crowley O.V., McKinley P.S., Burg M.M., Lachman M.E., Tun P.A., Ryff C.D., Seeman T.E., Sloan R.P. The association of cardiac vagal control and executive functioning - findings from the MIDUS study. Journal of Psychiatric Research 2013, 47:628-635.
34. Knaepen K., Goekint M., Heyman E.M., Meeusen R. Neuroplasticity - exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects. Sports Medicine 2010, 40:765-801.
35. Kramer A.F., Hahn S., Cohen N.J., Banich M.T., McAuley E., Harrison C.R., Chason J., Vakil E., Bardell L., Boileau R.A., Colcombe A. Ageing, fitness and neurocognitive function. Nature 1999, 400:418-419.
36. Lindamer L.A., McKibbin C., Norman G.J., Jordan L., Harrison K., Abeyesinhe S., Patrick K. Assessment of physical activity in middle-aged and older adults with schizophrenia. Schizophrenia Research 2008, 104:294-301.
37. McGurk S.R., Twamley E.W., Sitzer D.I., McHugo G.J., Mueser K.T. A meta-analysis of cognitive remediation in schizophrenia. The American Journal of Psychiatry 2007, 164:1791-1802.
38. American College of Sports Medicine Clinical exercise testing. ACSM's Guidelines for Exercise Testing and Supervision 2009, 105-135. Woulters Kluwer: Lippincott, Williams and Wilkins, Philadeplhia, PA. 8th edition. W.R. Thompson (Ed.).
39. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., Heaton R.K. Identification of separable cognitive factors in schizophrenia. Schizophrenia Tesearch 2004, 72:29-39.
40. Nuechterlein K.H., Green M.F. MATRICS Consensus Battery Manual 2006, MATRICS Assessment Inc., Los Angeles.
41. Ozbulut O., Genc A., Bagcioglu E., Coskun K.S., Acar T., Alkoc O.A., Karabacak H., Sener U., Ucok K. Evaluation of physical fitness parameters in patients with schizophrenia. Psychiatry Research 2013, 210:806-811.
42. Pajonk F.-G., Wobrock T., Gruber O., Scherk H., Berner D., Kaizl I., Kierer A., Muller S., Oest M., Meyer T., Backens M., Schneider-Axmann T., Thornton A.E., Honer W.G., Falkai P. Hippocampal plasticity in response to exercise in schizophrenia. Archives of General Psychiatry 2010, 67:133-143.
43. Physical Activity Guidelines for Americans, 2008. http://www.health.gov/paguidelines/.
44. Rasmussen P., Brassard P., Adser H., Pedersen M.V., Leick L., Hart E., Secher N.H., Pedersen B.K., Pilegaard H. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Experimental Physiology 2009, 94:1062-1069.
45. Rizos E.N., Papathanasiou M., Michalopoulou P.G., Mazioti A., Douzenis A., Kastania A., Nikolaidou P., Laskos E., Vasilopoulou K., Lykouras L. Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients. Schizophrenia Research 2011, 129:201-204.
46. Rizos E.N., Rontos I., Laskos E., Arsenis G., Michalopoulou P.G., Vasilopoulos D., Gournellis R., Lykouras L. Investigation of serum BDNF levels in drug-naive patients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008, 32:1308-1311.
47. Roick C., Fritz-Wieacker A., Matschinger H., Heider D., Schindler J., Riedel-Heller S., Angermeyer M.C. Health habits of patients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology 2007, 42:268-276.
48. Scheewe T.W., Backx F.J., Takken T., Jorg F., van Strater A.C., Kroes A.G., Kahn R.S., Cahn W. Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial. Acta Psychiatrica Scandinavica 2013, 127:464-473.
49. Schneider L.C., Struening E.L. SLOF: a behavioral rating scale for assessing the mentally ill. Social Work Research and Abstracts 1983, 19:9-21.
50. Seifert T., Brassard P., Wissenberg M., Rasmussen P., Nordby P., Stallknecht B., Adser H., Jakobsen A.H., Pilegaard H., Nielsen H.B., Secher N.H. Endurance training enhances BDNF release from the human brain. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2010, 298:R372-R377.
51. Shah N.R., Braverman E.R. Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin. PloS One 2012, 7:e33308.
52. Sharpe J.K., Stedman T.J., Byrne N.M., Wishart C., Hills A.P. Energy expenditure and physical activity in clozapine use: implications for weight management. Australian and New Zealand Journal of Psychiatry 2006, 40:810-814.
53. Siervo M., Arnold R., Wells J.C., Tagliabue A., Colantuoni A., Albanese E., Brayne C., Stephan B.C. Intentional weight loss in overweight and obese individuals and cognitive function: a systematic review and meta-analysis. Obesity Reviews 2011, 12:968-983.
54. Smith P.J., Blumenthal J.A., Hoffman B.M., Cooper H., Strauman T.A., Welsh-Bohmer K., Browndyke J.N., Sherwood A. Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosomatic Medicine 2010, 72:239-252.
55. Stanek K.M., Strain G., Devlin M., Cohen R., Paul R., Crosby R.D., Mitchell J.E., Gunstad J. Body mass index and neurocognitive functioning across the adult lifespan. Neuropsychology 2013, 27:141-151.
56. Strassnig M., Brar J.S., Ganguli R. Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia. Schizophrenia Research 2011, 126:103-109.
57. Tahmasian M., Khazaie H., Golshani S., Avis K.T. Clinical application of actigraphy in psychotic disorders: a systematic review. Current Psychiatry Reports 2013, 15:359.
58. van Praag H. Neurogenesis and exercise: past and future directions. Neuromolecular Medicine 2008, 10:128-140.
59. van Praag H. Exercise and the brain: something to chew on. Trends in Neurosciences 2009, 32:283-290.
60. Vancampfort D., De Hert M., De Herdt A., Vanden Bosch K., Soundy A., Bernard P.P., De Wachter D., Probst M. Associations between physical activity and the built environment in patients with schizophrenia: a multi-centre study. General Hospital Psychiatry 2013, 35:653-658.
61. Vancampfort D., Knapen J., Probst M., van Winkel R., Deckx S., Maurissen K., Peuskens J., De Hert M. Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia. Psychiatry Research 2010, 177:271-279.
62. Vancampfort D., Probst M., Helvik Skjaerven L., Catalan-Matamoros D., Lundvik-Gyllensten A., Gomez-Conesa A., Ijntema R., De Hert M. Systematic review of the benefits of physical therapy within a multidisciplinary care approach for people with schizophrenia. Physical Therapy 2012, 92:11-23.
63. Vancampfort D., Probst M., Scheewe T., Knapen J., De Herdt A., De Hert M. The functional exercise capacity is correlated with global functioning in patients with schizophrenia. Acta Psychiatrica Scandinavica 2012, 125:382-387.
64. Vancampfort D., Probst M., Sweers K., Maurissen K., Knapen J., De Hert M. Relationships between obesity, functional exercise capacity, physical activity participation and physical self-perception in people with schizophrenia. Acta Psychiatrica Scandinavica 2011, 123:423-430.
65. Vaynman S., Gomez-Pinilla F. License to run: exercise impacts functional plasticity in the intact and injured central nervous system by using neurotrophins. Neurorehabilitation and Neural Repair 2005, 19:283-295.
66. Vinogradov S., Fisher M., Nagarajan S. Cognitive training in schizophrenia: golden age or wild west?. Biological Psychiatry 2013, 73:935-937.
67. Wilmore J.H., Green J.S., Stanforth P.R., Gagnon J., Rankinen T., Leon A.S., Rao D.C., Skinner J.S., Bouchard C. Relationship of changes in maximal and submaximal aerobic fitness to changes in cardiovascular disease and non-insulin-dependent diabetes mellitus risk factors with endurance training: the HERITAGE Family Study. Metabolism: Clinical and Experimental 2001, 50:1255-1263.
68. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 2003, 64:663-667.
69. Wykes T., Huddy V., Cellard C., McGurk S.R., Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. American Journal of Psychiatry 2011, 168:472-485.
70. Zhang X., Liang J., Chen D., Xiu M., De Yang F., Kosten T., Kosten T. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology 2012, 1-8.